Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects
Silvius Stanciu, Florentina Ioniţă‐Radu, Constantin Ştefani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10132-10132
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154438-154438
Closed Access | Times Cited: 50
Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance
Chunjie Huang, Paniz Azizi, Masoud Vazirzadeh, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Heng‐Chung Kung, Jun Yu
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 23
Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations
Prasanna Mohite, Deepak K. Lokwani, Nikhil S. Sakle
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 6107-6119
Closed Access | Times Cited: 6
Regulation of pancreatic cancer cells by suppressing KIN17 through the PI3K/AKT/mTOR signaling pathway
Qiuyan Li, Yuxia Yang, Xiaocong Lin, et al.
Oncology Reports (2025) Vol. 53, Iss. 2
Closed Access
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Farnesol Inhibits Cell Viability and Activates Apoptosis in Glioma C6 Cells via Downregulating Phosphoinositide 3-kinase (PI3K)/Protein Kinase B (AKT)/Mammalian Target of Rapamycin (mTOR) Pathway
Chao Gao, Shu-Jem Su, Qi Guan, et al.
Pharmacognosy Magazine (2025)
Closed Access
Investigation of Scutellaria Barbata’s immunological mechanism against thyroid cancer using network pharmacology and experimental validation
Gen Ouyang, Yuangui Zhu, Zhihua Ouyang
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Identifying Hub Genes and Pathways in Pancreatic Ductal Adenocarcinoma (PAAD): A comprehensive in silico study
Elham Karimi, Niloufar Sadat Kalaki, Seyed Mohammad Akrami
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101921-101921
Closed Access
Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic Adenocarcinomas
Jerry Xiao, Reetu Mukherji, George Sidarous, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 355-355
Open Access
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
Bedanta Bhattacharjee, Ayesha Farhana Syeda, Damanbhalang Rynjah, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3406-3406
Open Access | Times Cited: 5
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Cannabigerol Induces Autophagic Cell Death by Inhibiting EGFR-RAS Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines
Laura Zeppa, Cristina Aguzzi, Maria Beatrice Morelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2001-2001
Open Access | Times Cited: 4
Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular
Ou Li, Li Li, Yunru Sheng, et al.
Cancer Letters (2023) Vol. 574, pp. 216391-216391
Open Access | Times Cited: 13
Cannabigerol Induces Autophagic-Cell Death by Inhibiting EGFR-RAS-Pathways in Human Pancreatic Ductal Adenocarcinoma Cell Lines
Laura Zeppa, Cristina Aguzzi, Maria Beatrice Morelli, et al.
(2024)
Open Access | Times Cited: 3
A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors
Toshihiko Doi, Shunji Takahashi, Daisuke Aoki, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 93, Iss. 6, pp. 605-616
Open Access | Times Cited: 3
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer
Diego J. Jiménez, Aadil Javed, Teresa Rubio‐Tomás, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2860-2860
Open Access | Times Cited: 3
Long Noncoding RNAs and Cancer Stem Cells: Dangerous Liaisons Managing Cancer
Silvia Anna Ciafrè, Monia Russo, Alessandro Michienzi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1828-1828
Open Access | Times Cited: 10
Biological function, regulatory mechanism, and clinical application of mannose in cancer
Haoyi Jin, Xi Liu, Hongxu Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188970-188970
Closed Access | Times Cited: 10
Targeting Pancreatic Cancer with Novel Plumbagin Derivatives: Design, Synthesis, Molecular Mechanism, In Vitro and In Vivo Evaluation
Suresh Awale, Hayato Baba, Nguyễn Duy Phan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 8054-8065
Closed Access | Times Cited: 9
Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
Y Xiang, Yingxin Yang, Jia Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer
Diego J Jiménez, Aadil Javed, Teresa Rubio‐Tomás, et al.
(2024)
Open Access | Times Cited: 2
Feasible mechanisms and therapeutic potential of food probiotics to mitigate diabetes‐associated cancers: A comprehensive review and in silico validation
Annadurai Vinothkanna, Xiang Shi‐Liang, Durairaj Karthick Rajan, et al.
Food Frontiers (2024) Vol. 5, Iss. 4, pp. 1476-1511
Open Access | Times Cited: 2
Neuromedin U regulates the anti‐tumor activity of CD8+ T cells and glycolysis of tumor cells in the tumor microenvironment of pancreatic ductal adenocarcinoma in an NMUR1‐dependent manner
Rui Zheng, Si Wang, Jia Wang, et al.
Cancer Science (2023) Vol. 115, Iss. 2, pp. 334-346
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top